The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dose escalation of KY-0118, PD-1, and IL-2v due-target fusion protein in patients with advanced renal clear cell carcinoma, urothelial carcinoma, and malignant melanoma.
 
Guoxiang Wu
Employment - Novatim Immune Therapeutics
Leadership - Novatim Immune Therapeutics
Stock and Other Ownership Interests - Novatim Immune Therapeutics
 
Dianwen Ju
No Relationships to Disclose
 
Yahui Su
Employment - Novatim Immune Therapeutics
Leadership - Novatim Immune Therapeutics
 
Helen Yu
Employment - Novatim Immune Therapeutics
Leadership - Novatim Immune Therapeutics